Totus recruits Singer as first CFO
Plus updates from Pharmaron, Adverum, Azenta, InterVenn and more
Totus Medicines Inc., a drug discovery company based in Cambridge, Mass., hired its first-ever CFO — Sam Singer, a former VP at Granahan Investment Management. Totus raised a $40 million series A in December and expects to start clinical testing of its PI3Kα inhibitor TOS-358 in 2H22.
CRO Pharmaron Beijing Co. Ltd. (SZSE:300759; HKEX:3759) hired Sid Bhoopathy as SVP, US head of laboratory services and CGT, effective Nov. 1, 2021. Bhoopathy was previously president and COO at Absorption Systems, which Pharmaron acquired in 2020. ...